Coagulation Factor IX (F9) Antibody

This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease.

Target	Coagulation Factor IX (F9)
Clonality	Polyclonal
Reactivity	Human
Tested Applications	ELISA, WB
Host	Rabbit
Recommended dilutions	WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	KLH-conjugated synthetic peptide between 266-295 amino acids from the Central region of human F9.
Isotype	IgG
Form	Liquid
Purification	Purified through a protein A column, followed by peptide affinity purification.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC	P00740 (UniProt, ExPASy)
UniProt Secondary AC	A8K9N4, F2RM36, Q5FBE1, Q5JYJ8
UniProt Entry Name	FA9_HUMAN
Gene Symbol	F9
KEGG	hsa:2158
String	9606.ENSP00000218099
Molecular Weight	Calculated MW: 51.8 kDa
Buffer	PBS containing 0.09% sodium azide.
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.

Research Articles on Coagulation Factor IX (F9)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue